Drug giant Eli Lilly reported weaker-than-expected earnings but the stock is soaring. Eli Lilly reported a year-over-year leap in second-quarter sales, but much of that rise resulted from the world’s ...
Source LinkDrug giant Eli Lilly reported weaker-than-expected earnings but the stock is soaring. Eli Lilly reported a year-over-year leap in second-quarter sales, but much of that rise resulted from the world’s ...
Source Link
Comments